Related references
Note: Only part of the references are listed.Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
MOLECULAR THERAPY (2011)
Prime-boost vectored malaria vaccines Progress and prospects
Adrian V. S. Hill et al.
HUMAN VACCINES (2010)
Enhancing Blood-Stage Malaria Subunit Vaccine Immunogenicity in Rhesus Macaques by Combining Adenovirus, Poxvirus, and Protein-in-Adjuvant Vaccines
Simon J. Draper et al.
JOURNAL OF IMMUNOLOGY (2010)
Reduced evolvability of Escherichia coli MDS42, an IS-less cellular chassis for molecular and synthetic biology applications
Kinga Umenhoffer et al.
MICROBIAL CELL FACTORIES (2010)
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
Stefania Capone et al.
VACCINE (2010)
Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys
Jonatan Ersching et al.
VIROLOGY (2010)
The Influence of Innate and Pre-Existing Immunity on Adenovirus Therapy
Anne K. Zaiss et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine
Larissa Herkenhoff Haut et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
New Insights on Adenovirus as Vaccine Vectors
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2009)
Viral vectors in malaria vaccine development
K. J. Limbach et al.
PARASITE IMMUNOLOGY (2009)
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectors
Sampa Santra et al.
VACCINE (2009)
Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function
Richard J. Stanton et al.
BIOTECHNIQUES (2008)
The complete genome sequence of Escherichia coli DH10B:: Insights into the biology of a laboratory workhorse
Tim Durfee et al.
JOURNAL OF BACTERIOLOGY (2008)
Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A
S. Sridhar et al.
JOURNAL OF VIROLOGY (2008)
Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against tuberculosis
Zhou Xing et al.
EXPERT REVIEW OF VACCINES (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Emergent properties of reduced-genome Escherichia coli
G Pósfai et al.
SCIENCE (2006)
Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity
DM Roberts et al.
NATURE (2006)
Prime-boost immunisation strategies for tuberculosis
H McShane et al.
MICROBES AND INFECTION (2005)
Increased protein expression from adenoviral shuttle plasmids and vectors by insertion of a small chimeric intron sequence
S Hermening et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells
G Gao et al.
GENE THERAPY (2003)
Comparative analysis of the effects of packaging signal, transgene orientation, promoters, polyadenylation signals, and E3 region on growth properties of first-generation adenoviruses
R Youil et al.
HUMAN GENE THERAPY (2003)
Pfs230: from malaria transmission-blocking vaccine candidate toward function
KC Williamson
PARASITE IMMUNOLOGY (2003)
An Escherichia coli strain, BJ5183, that shows highly efficient conservative (two-progeny) DNA double-strand break repair of restriction breaks
N Takahashi et al.
GENE (2003)
Share Paper
